Related Experiment Video
Updated: Jan 5, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
[KLF3 regulates the movement, migration and invasion of breast cancer cells through STAT3]
1Department of Breast Surgery, Henan Provincial People's Hospital, Zhengzhou 450003, China.
Abstract:
Objective: To observe the effect of KLF3 on the expression of STAT3 in breast cancer cells, and to explore the potential mechanism of KLF3 affecting the movement, migration and invasion of breast cancer cells. Methods: Firstly, the expression of STAT3 was detected by Western blot, real-time fluorescent quantitative PCR, luciferase reporter system and chromatin immunoprecipitation in breast cancer cells. Secondly, the STAT3 promoter mutant was constructed. The plasmid further confirmed the effect of KLF3 on the activity of STAT3 promoter; the cell scratching test and Transwell method were used to detect the ability of cell movement, migration and invasion. Finally, animal experiments were conducted to verify the effect of knockdown of KLF3 on tumor metastasis in animals. Results: In breast cancer cells, knockdown of KLF3 promoted STAT3 protein expression. The mRNA level of STAT3 was increased by (3.58±0.65) fold after knockdown of KLF3 in MDA-MB-231 cells, while the mRNA level of STAT3 was increased by (2.28±0.19) fold after KLF3 knockdown in MCF-7 cells (P<0.001). KLF3 boundto the promoter region of STAT3. The transcriptional activity of STAT3 increased by (2.47±0.87) fold after knockdown of KLF3 in MDA-MB-231 cells, while the transcriptional activity of STAT3 increased by (2.63±0.65) fold after KLF3 knockdown in MCF-7 cells, P<0.01. KLF3 knockdown inhibitedthe movement,migrate and invade of breast cancer cells. Based on this, silence STAT3 partially reversed the function of KLF3. Knockdown of KLF3 promotedtumor metastasis in mice. Conclusions: KLF3 knockdown can promote the transcriptional activity of STAT3, which promotes the protein expression of the latter. KLF3 can affect the movement, migration and invasion of breast cancer cells through STAT3. KLF3 may be a potential target for the treatment of metastatic breast cancer.
Insights
Krüppel-like factor 3 (KLF3) knockdown increases Signal transducer and activator of transcription 3 (STAT3) expression and transcriptional activity in breast cancer cells. KLF3 impacts breast cancer cell movement and invasion, suggesting KLF3 as a potential therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Signal transducer and activator of transcription 3 (STAT3) is frequently dysregulated in various cancers, including breast cancer.
- Krüppel-like factor 3 (KLF3) is a transcription factor with known roles in cellular differentiation and development, but its specific function in breast cancer progression remains to be fully elucidated.
Purpose of the Study:
- To investigate the effect of KLF3 on STAT3 expression in breast cancer cells.
- To explore the underlying mechanism by which KLF3 influences breast cancer cell migration, invasion, and metastasis.
Main Methods:
- Western blot, RT-qPCR, and luciferase reporter assays were employed to assess STAT3 expression and transcriptional activity.
- Chromatin immunoprecipitation (ChIP) was used to determine KLF3 binding to the STAT3 promoter.
- Cellular assays (scratch, Transwell) and in vivo animal models were utilized to evaluate cell migration, invasion, and metastasis.
Main Results:
- KLF3 knockdown led to increased STAT3 protein and mRNA levels and enhanced STAT3 transcriptional activity in breast cancer cell lines (MDA-MB-231 and MCF-7).
- KLF3 directly binds to the promoter region of STAT3.
- KLF3 knockdown inhibited breast cancer cell movement, migration, and invasion, effects partially reversed by STAT3 silencing. In vivo studies showed KLF3 knockdown promoted tumor metastasis.
Conclusions:
- KLF3 functions as a negative regulator of STAT3 transcription and activity in breast cancer.
- KLF3 suppresses breast cancer cell migration, invasion, and metastasis, at least in part, through the modulation of STAT3.
- KLF3 represents a promising therapeutic target for managing metastatic breast cancer.
Related Concept Videos
Cancer Cell Migration through Invadopodia
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cell Migration
The JAK-STAT Signaling Pathway

